Concepedia

Maryann Powles

MP

Statistics

Publications

16

Citations

628

H-Index

14

Active since

1972

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Scynexis (United States)

Maryann Powles is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, pneumocystis infection, and antimicrobial pharmacology.

Publications per year

1972–2020

16

Publications

16

Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes

Margaret Wu, Sheo B. Singh, Jun Wang et al. · Proceedings of the National Academy of Sciences · 2011 · 146 citations

, , +17

Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.

Dennis M. Schmatz, George K. Abruzzo, Maryann Powles et al. · The Journal of Antibiotics · 1992 · 64 citations · Full text

, , +10

Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor

James M. Apgar, Robert R. Wilkening, Dann L. Parker et al. · Bioorganic & Medicinal Chemistry Letters · 2020 · 50 citations

, , +4

Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection

Maryann Powles, D C McFadden, L A Pittarelli et al. · Infection and Immunity · 1992 · 47 citations · Full text

, , +16

New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat

Dennis M. Schmatz, Maryann Powles, D C McFadden et al. · Antimicrobial Agents and Chemotherapy · 1995 · 44 citations

, , +11

1–5 of 16